Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.8%

168 terminated/withdrawn out of 2880 trials

Success Rate

92.5%

+6.0% vs industry average

Late-Stage Pipeline

8%

236 trials in Phase 3/4

Results Transparency

43%

888 of 2084 completed trials have results

Key Signals

329 recruiting888 with results95 terminated73 withdrawn

Enrollment Performance

Analytics

N/A
1264(48.7%)
Phase 2
563(21.7%)
Phase 1
443(17.1%)
Phase 4
121(4.7%)
Phase 3
115(4.4%)
Early Phase 1
91(3.5%)
2597Total
N/A(1264)
Phase 2(563)
Phase 1(443)
Phase 4(121)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2880)

Showing 20 of 2880 trials
NCT07099092Early Phase 1Not Yet Recruiting

Causal Mechanisms of Odor-Guided Behavior in Humans

Role: lead

NCT06107062Phase 2Recruiting

Longitudinal Outpatient Treatment for Cannabis Use Disorder

Role: collaborator

NCT07024498Not ApplicableRecruiting

Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment

Role: collaborator

NCT06676059Recruiting

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Role: lead

NCT06577454Not ApplicableSuspended

Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

Role: lead

NCT06456242Not ApplicableCompleted

Contingency Management to Promote Smoking Cessation

Role: collaborator

NCT06860607Phase 1Recruiting

Environment and Alcohol: A Pilot Study

Role: lead

NCT06561828Early Phase 1Recruiting

Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making

Role: lead

NCT06868914Phase 1Not Yet Recruiting

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Role: lead

NCT06995885Enrolling By Invitation

Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

Role: lead

NCT07637669Not Yet Recruiting

Olfactory Function and Model-Based Behavior in People Living With HIV and SUD

Role: lead

NCT01117753Not ApplicableCompleted

Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders

Role: collaborator

NCT06096714Early Phase 1Recruiting

Addictive Threshold of Nicotine

Role: collaborator

NCT07340554Not ApplicableRecruiting

Neuroimaging of Adolescent Cannabis Use Treatment

Role: collaborator

NCT07116837Not ApplicableActive Not Recruiting

Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults

Role: collaborator

NCT06109571Not ApplicableActive Not Recruiting

Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders

Role: collaborator

NCT03407638Not ApplicableCompleted

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Role: collaborator

NCT06799117Not ApplicableRecruiting

Adaptive Decision Support for Addiction Treatment Master

Role: collaborator

NCT07602335Early Phase 1Not Yet Recruiting

Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants

Role: collaborator

NCT07105449Not ApplicableRecruiting

THC Titration of High-Potency Cannabis Concentrates

Role: collaborator